-
1
-
-
33645675960
-
Estimating the cost of new drug development: Is it really 802 million dollars?
-
10.1377/hlthaff.25.2.420
-
CP Adams VV Brantner 2006 Estimating the cost of new drug development: is it really 802 million dollars? Health Aff (Millwood) 25 2 420 428 10.1377/hlthaff.25.2.420
-
(2006)
Health Aff (Millwood)
, vol.25
, Issue.2
, pp. 420-428
-
-
Adams, C.P.1
Brantner, V.V.2
-
2
-
-
0028874181
-
GR159897, a potent non-peptide antagonist at tachykinin NK2 receptors
-
10.1016/0014-2999(94)00655-Q 1:CAS:528:DyaK2MXjt1Smsrw%3D 7713168
-
IJ Beresford, et al. 1995 GR159897, a potent non-peptide antagonist at tachykinin NK2 receptors Eur J Pharmacol 272 2-3 241 248 10.1016/0014-2999(94) 00655-Q 1:CAS:528:DyaK2MXjt1Smsrw%3D 7713168
-
(1995)
Eur J Pharmacol
, vol.272
, Issue.23
, pp. 241-248
-
-
Beresford, I.J.1
-
3
-
-
23044504046
-
How many genomics targets can a portfolio afford?
-
DOI 10.1016/S1359-6446(05)03498-7, PII S1359644605034987
-
UAK Betz 2005 How many genomics targets can a portfolio afford? Drug Discov Today 10 15 1057 1063 10.1016/S1359-6446(05)03498-7 16055022 (Pubitemid 41074144)
-
(2005)
Drug Discovery Today
, vol.10
, Issue.15
, pp. 1057-1063
-
-
Betz, U.A.K.1
-
4
-
-
66049129455
-
Assessment of methods and analysis of outcomes for comprehensive optimization of nucleofection
-
10.1186/1479-0556-7-6 19432988
-
C Bradburne K Robertson D Thach 2009 Assessment of methods and analysis of outcomes for comprehensive optimization of nucleofection Genet Vaccines Ther 7 6 10.1186/1479-0556-7-6 19432988
-
(2009)
Genet Vaccines Ther
, vol.7
, pp. 6
-
-
Bradburne, C.1
Robertson, K.2
Thach, D.3
-
5
-
-
35148830392
-
Evolution of cell-based reagent provision
-
DOI 10.1016/j.drudis.2007.08.014, PII S135964460700356X
-
D Cawkill SS Eaglestone 2007 Evolution of cell-based reagent provision Drug Discov Today 12 19-20 820 825 10.1016/j.drudis.2007.08.014 1:CAS:528:DC%2BD2sXhtFKitrfL 17933682 (Pubitemid 47539971)
-
(2007)
Drug Discovery Today
, vol.12
, Issue.19-20
, pp. 820-825
-
-
Cawkill, D.1
Eaglestone, S.S.2
-
6
-
-
0024236673
-
The mechanism of conservative site-specific recombination
-
10.1146/annurev.ge.22.120188.000453 1:CAS:528:DyaL1MXhs1Krt7g%3D 3071260
-
NL Craig 1988 The mechanism of conservative site-specific recombination Ann Rev Genet 22 77 105 10.1146/annurev.ge.22.120188.000453 1:CAS:528: DyaL1MXhs1Krt7g%3D 3071260
-
(1988)
Ann Rev Genet
, vol.22
, pp. 77-105
-
-
Craig, N.L.1
-
7
-
-
41949098086
-
Nucleofection is a highly effective gene transfer technique for human melanoma cell lines
-
10.1111/j.1600-0625.2007.00687.x 1:CAS:528:DC%2BD1cXmslKlt7s%3D 18312380
-
CY Han, et al. 2008 Nucleofection is a highly effective gene transfer technique for human melanoma cell lines Exp Dermatol 17 5 405 411 10.1111/j.1600-0625.2007.00687.x 1:CAS:528:DC%2BD1cXmslKlt7s%3D 18312380
-
(2008)
Exp Dermatol
, vol.17
, Issue.5
, pp. 405-411
-
-
Han, C.Y.1
-
8
-
-
0035489204
-
Reporter-gene systems for the study of G-protein-coupled receptors
-
DOI 10.1016/S1471-4892(01)00091-1
-
SJ Hill, et al. 2001 Reporter-gene systems for the study of G-protein-coupled-receptors Curr Opin Pharmacol 1 526 532 10.1016/S1471-4892(01) 00091-1 1:CAS:528:DC%2BD3MXnsFOisr8%3D 11764780 (Pubitemid 33593844)
-
(2001)
Current Opinion in Pharmacology
, vol.1
, Issue.5
, pp. 526-532
-
-
Hill, S.J.1
Baker, J.G.2
Rees, S.3
-
9
-
-
7244245762
-
Finishing the euchromatic sequence of the human genome
-
DOI 10.1038/nature03001
-
Human Genome Sequencing Consortium 2004 Finishing the euchromatic sequence of the human genome Nature 431 7011 931 945 10.1038/nature03001 (Pubitemid 39434409)
-
(2004)
Nature
, vol.431
, Issue.7011
, pp. 931-945
-
-
Collins, F.S.1
Lander, E.S.2
Rogers, J.3
Waterson, R.H.4
-
10
-
-
27144434813
-
Techniques: Promiscuous Gα proteins in basic research and drug discovery
-
DOI 10.1016/j.tips.2005.09.007, PII S0165614705002397
-
E Kostenis M Waelbroeck G Milligan 2005 Techniques: promiscuous Galpha proteins in basic research and drug discovery Trends Pharmacol Sci 26 11 595 602 10.1016/j.tips.2005.09.007 1:CAS:528:DC%2BD2MXhtFKhsrrM 16183138 (Pubitemid 41505228)
-
(2005)
Trends in Pharmacological Sciences
, vol.26
, Issue.11
, pp. 595-602
-
-
Kostenis, E.1
Waelbroeck, M.2
Milligan, G.3
-
11
-
-
17344364488
-
Application of division arrest technology of cell-based HTS: Comparison with frozen and fresh cells
-
DOI 10.1089/adt.2005.3.17
-
P Kunapuli, et al. 2005 Application of division arrest technology to cell-based HTS: comparison with frozen and fresh cells Assay Drug Dev Technol 3 1 17 26 10.1089/adt.2005.3.17 1:CAS:528:DC%2BD2MXislagu7Y%3D 15798392 (Pubitemid 40533249)
-
(2005)
Assay and Drug Development Technologies
, vol.3
, Issue.1
, pp. 17-26
-
-
Kunapuli, P.1
Zheng, W.2
Weber, M.3
Solly, K.4
Mull, R.5
Platchek, M.6
Cong, M.7
Zhong, Z.8
Strulovici, B.9
-
12
-
-
0027397351
-
Tachykinin receptors and tachykinin receptor antagonists
-
10.1111/j.1474-8673.1993.tb00396.x 1:CAS:528:DyaK3sXhtl2qu74%3D 8382703
-
CA Maggi R Patacchini P Rovero A Giachetti 1993 Tachykinin receptors and tachykinin receptor antagonists J Auton Pharmacol 13 1 23 93 10.1111/j.1474-8673.1993.tb00396.x 1:CAS:528:DyaK3sXhtl2qu74%3D 8382703
-
(1993)
J Auton Pharmacol
, vol.13
, Issue.1
, pp. 23-93
-
-
Maggi, C.A.1
Patacchini, R.2
Rovero, P.3
Giachetti, A.4
-
13
-
-
79951779464
-
The cost of developing a new drug
-
US Department of State (eds) US Department of State Washington, DC
-
Masia N. The cost of developing a new drug. In: US Department of State, editor. Focus on: intellectual property rights. Washington, DC: US Department of State; 2006. p. 82-3.
-
(2006)
Focus On: Intellectual Property Rights
, pp. 82-83
-
-
Masia, N.1
-
14
-
-
34447580978
-
The A, B, Cs of G-protein-coupled receptor pharmacology in assay development for HTS
-
DOI 10.1517/17460441.2.5.603
-
DJ McLoughlin F Bertelli C Williams 2007 The A, B, Cs of G-protein-coupled receptor pharmacology in assay development for HTS Expert Opin Drug Discov 2 5 603 619 10.1517/17460441.2.5.603 1:CAS:528:DC%2BD2sXotFyntbc%3D (Pubitemid 47071655)
-
(2007)
Expert Opinion on Drug Discovery
, vol.2
, Issue.5
, pp. 603-619
-
-
McLoughlin, D.J.1
Bertelli, F.2
Williams, C.3
-
15
-
-
33751547539
-
How many drug targets are there?
-
DOI 10.1038/nrd2199, PII NRD2199
-
JP Overington B Al-Lazikani AL Hopkins 2006 How many drug targets are there? Nat Rev Drug Discov 5 993 996 10.1038/nrd2199 1:CAS:528: DC%2BD28Xht1Kju7jM 17139284 (Pubitemid 44835126)
-
(2006)
Nature Reviews Drug Discovery
, vol.5
, Issue.12
, pp. 993-996
-
-
Overington, J.P.1
Al-Lazikani, B.2
Hopkins, A.L.3
-
16
-
-
0028148244
-
Site-specific recombination: Developments and applications
-
DOI 10.1016/0958-1669(94)90068-X
-
B Sauer 1994 Site-specific recombination: developments and applications Curr Opin Biotechnol 5 521 527 10.1016/0958-1669(94)90068-X 1:CAS:528: DyaK2MXhvV2gu70%3D 7765467 (Pubitemid 24321421)
-
(1994)
Current Opinion in Biotechnology
, vol.5
, Issue.5
, pp. 521-527
-
-
Sauer, B.1
-
17
-
-
0035895505
-
The sequence of the human genome
-
DOI 10.1126/science.1058040
-
C Venter, et al. 2001 The sequence of the human genome Science 291 1304 1351 10.1126/science.1058040 1:CAS:528:DC%2BD3MXhtlSgsbo%3D 11181995 (Pubitemid 32173090)
-
(2001)
Science
, vol.291
, Issue.5507
, pp. 1304-1351
-
-
Craig Venter, J.1
Adams, M.D.2
Myers, E.W.3
Li, P.W.4
Mural, R.J.5
Sutton, G.G.6
Smith, H.O.7
Yandell, M.8
Evans, C.A.9
Holt, R.A.10
Gocayne, J.D.11
Amanatides, P.12
Ballew, R.M.13
Huson, D.H.14
Wortman, J.R.15
Zhang, Q.16
Kodira, C.D.17
Zheng, X.H.18
Chen, L.19
Skupski, M.20
Subramanian, G.21
Thomas, P.D.22
Zhang, J.23
Gabor Miklos, G.L.24
Nelson, C.25
Broder, S.26
Clark, A.G.27
Nadeau, J.28
McKusick, V.A.29
Zinder, N.30
Levine, A.J.31
Roberts, R.J.32
Simon, M.33
Slayman, C.34
Hunkapiller, M.35
Bolanos, R.36
Delcher, A.37
Dew, I.38
Fasulo, D.39
Flanigan, M.40
Florea, L.41
Halpern, A.42
Hannenhalli, S.43
Kravitz, S.44
Levy, S.45
Mobarry, C.46
Reinert, K.47
Remington, K.48
Abu-Threideh, J.49
Beasley, E.50
Biddick, K.51
Bonazzi, V.52
Brandon, R.53
Cargill, M.54
Chandramouliswaran, I.55
Charlab, R.56
Chaturvedi, K.57
Deng, Z.58
Di Francesco, V.59
Dunn, P.60
Eilbeck, K.61
Evangelista, C.62
Gabrielian, A.E.63
Gan, W.64
Ge, W.65
Gong, F.66
Gu, Z.67
Guan, P.68
Heiman, T.J.69
Higgins, M.E.70
Ji, R.-R.71
Ke, Z.72
Ketchum, K.A.73
Lai, Z.74
Lei, Y.75
Li, Z.76
Li, J.77
Liang, Y.78
Lin, X.79
Lu, F.80
Merkulov, G.V.81
Milshina, N.82
Moore, H.M.83
Naik, A.K.84
Narayan, V.A.85
Neelam, B.86
Nusskern, D.87
Rusch, D.B.88
Salzberg, S.89
Shao, W.90
Shue, B.91
Sun, J.92
Zhen Yuan Wang93
Wang, A.94
Wang, X.95
Wang, J.96
Wei, M.-H.97
Wides, R.98
Xiao, C.99
more..
-
18
-
-
44849103414
-
Use of cryopreserved cells for enabling greater flexibility in compound profiling
-
DOI 10.1177/1087057108317768
-
MJ Wigglesworth, et al. 2008 Use of cryopreserved cells for enabling greater flexibility in compound profiling J Biomol Screen 13 5 354 362 10.1177/1087057108317768 1:CAS:528:DC%2BD1cXotlCms7g%3D 18467669 (Pubitemid 351793986)
-
(2008)
Journal of Biomolecular Screening
, vol.13
, Issue.5
, pp. 354-362
-
-
Wigglesworth, M.J.1
Lawless, K.J.2
Standing, D.J.3
Mackenzie, E.K.4
Kitchen, V.R.5
McKay, F.6
Ward, E.7
Brough, S.J.8
Stylianou, M.9
Jewitt, F.R.10
McLaren-Douglas, A.M.11
Jowet, M.I.12
Tamayama, N.13
Finnigan, D.14
Ding, J.15
Wise, A.16
|